4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-23-028725
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Moses Jennifer K. Director | 2023-06-14 | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | D | ||
Loading xslF345X04/ownership.xml…